+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Viability Assays Market - Global Forecast 2026-2032- Product Image
Cell Viability Assays Market - Global Forecast 2026-2032- Product Image
New

Cell Viability Assays Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010770
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell viability assays market is transforming as laboratories adopt automation, digital analytics, and innovative assay chemistries to streamline experiment design and enhance data reliability across global research, clinical, and contract settings.

Market Snapshot: Cell Viability Assays Market

The Cell Viability Assays Market grew from USD 2.22 billion in 2025 to USD 2.48 billion in 2026. Driven by consistent demand for reproducible and sensitive cellular analysis, the market is forecast to expand at a CAGR of 11.77%, ultimately reaching USD 4.85 billion by 2032.

Scope & Segmentation

  • Product Types: Assay kits (colorimetric, fluorometric, luminescent), instruments, software, and supportive consumables. Each product group caters to specific laboratory workflow needs, from basic research to high-throughput drug screening.
  • Detection Methods: Includes colorimetric, chemiluminescent, fluorometric, and ATP-based luminescent approaches, enabling diverse sensitivity levels and compatibility with multiple cellular models and downstream applications.
  • End Users: Academic institutions, clinical laboratories, contract research organizations, pharmaceutical and biotechnology firms, and diagnostic centers, each prioritizing aspects such as throughput, flexibility, or integration with clinical protocols.
  • Applications: Utilized in basic cell research, proliferation studies, cytotoxicity assessments, and preclinical drug testing, underpinning decision support from early discovery through regulatory submission.
  • Regional Coverage: North America, Europe, Middle East & Africa, Asia-Pacific, and Latin America regions. Market strategies reflect regional distinctions in regulatory requirements, procurement preferences, and focus areas such as translational research or manufacturing agility.
  • Technologies: Advances in fluorometric and luminescent chemistries, instrument automation, digital analytics, and cloud-integrated software that support both large-scale screenings and hypothesis-driven experiments.

Key Takeaways

  • Laboratories can now select assays tailored to both sensitivity and throughput, guided by well-developed segmentation across detection methods and product formats.
  • Integration of digital analytics and machine learning capabilities is becoming standard, enhancing reproducibility and allowing labs to streamline multi-site collaboration and method transfer.
  • Growing adoption of modular, automated platforms supports both large contract research campaigns and flexible, small-scale studies without compromising data quality.
  • Assay suppliers and instrument vendors routinely supply comprehensive validation and standardized protocols, addressing rising demands for reproducibility and supporting regulatory submission requirements.
  • Transition to complex cell models, such as co-cultures and 3D systems, prompts ongoing assay innovation to preserve physiological relevance and deliver robust measurements in challenging environments.
[ImageId=5678efgh-efgh-5678-9101-abcdef654321]

Tariff Impact and Procurement Strategies

Recent tariff trends have significantly influenced laboratory procurement and global supply chain management. Labs and suppliers are responding by:

  • Prioritizing the diversification of suppliers and nearshoring strategies to maintain reliable access to key assay kits, consumables, and instruments.
  • Accelerating local manufacturing, establishing regional distribution centers, and adapting supply routes to minimize exposure to trade restrictions or pricing instability.
  • Securing longer-term supply agreements and increasing safety stock levels to hedge against shipment disruptions or cost fluctuations.
  • Modifying product design, packaging, or licensing models to optimize for customs procedures and reduce dependence on hardware shipments.

Methodology & Data Sources

This report applies a mixed-methods research approach, combining structured interviews with laboratory stakeholders and expert practitioners with systematic review of industry literature, supplier validation documents, and regulatory filings. Findings were triangulated to ensure robust and actionable insights relevant to operational and procurement challenges.

Why This Report Matters

  • Provides senior decision-makers and procurement leaders with actionable market intelligence to inform strategy, vendor selection, and investment in resilient assay platforms.
  • Clarifies the interplay between evolving technologies, segmentation criteria, and regional procurement dynamics, supporting better alignment of product offerings with laboratory priorities.
  • Enables organizations to anticipate supply chain risks and adapt to regulatory changes, strengthening operational continuity and compliance.

Conclusion

Organizations that integrate advanced assay solutions, resilient supply practices, and rigorous validation protocols will be best positioned to drive reliable research outcomes and operational efficiency in the cell viability assays market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cell Viability Assays Market, by Product Type
8.1. Assay Kits
8.1.1. Colorimetric Kits
8.1.2. Fluorometric Kits
8.1.3. Luminescent Kits
8.2. Instruments
8.3. Software
9. Cell Viability Assays Market, by Detection Method
9.1. Chemiluminescent
9.2. Colorimetric
9.3. Fluorometric
9.3.1. Calcein AM
9.3.2. Resazurin
9.4. Luminescent
9.4.1. ATP
9.4.2. Luciferase
10. Cell Viability Assays Market, by Application
10.1. Basic Research
10.2. Cell Proliferation Studies
10.3. Cytotoxicity Testing
10.4. Drug Screening
11. Cell Viability Assays Market, by End User
11.1. Academic And Research Institutions
11.2. Contract Research Organizations
11.3. Hospitals And Diagnostic Centers
11.4. Pharmaceutical And Biotechnology Companies
12. Cell Viability Assays Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Cell Viability Assays Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Cell Viability Assays Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Cell Viability Assays Market
16. China Cell Viability Assays Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AAT Bioquest, Inc.
17.6. Abcam PLC
17.7. Agilent Technologies, Inc.
17.8. Akadeum Life Sciences
17.9. Assay Genie
17.10. Becton, Dickinson and Company
17.11. Bio-Rad Laboratories, Inc.
17.12. Bio-Techne Corporation
17.13. Biotium, Inc.
17.14. BMG LABTECH GmbH
17.15. Cell Biolabs, Inc.
17.16. Creative Bioarray
17.17. Danaher Corporation
17.18. Elabscience Biotechnology Inc.
17.19. Enzo Life Sciences, Inc.
17.20. F. Hoffmann-La Roche AG
17.21. GE HealthCare Technologies, Inc.
17.22. Hemogenix Inc.
17.23. Illumina, Inc
17.24. Merck KGaA
17.25. Miltenyi Biotec B.V. & Co. KG
17.26. PerkinElmer, Inc.
17.27. Promega Corporation
17.28. Qiagen N.V.
17.29. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CHEMILUMINESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CHEMILUMINESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CALCEIN AM, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CALCEIN AM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CALCEIN AM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY RESAZURIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY RESAZURIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY RESAZURIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ATP, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ATP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ATP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUCIFERASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUCIFERASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUCIFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL PROLIFERATION STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL PROLIFERATION STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL PROLIFERATION STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CYTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CYTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 112. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 113. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 114. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 127. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 128. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 129. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 130. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 144. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 145. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 146. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 147. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. ASEAN CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 152. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 153. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 154. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 155. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. GCC CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 168. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 169. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 170. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 171. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. BRICS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 176. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 177. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 178. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 179. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. G7 CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 184. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 185. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 186. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 187. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. NATO CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. CHINA CELL VIABILITY ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2032 (USD MILLION)
TABLE 201. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
TABLE 202. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2032 (USD MILLION)
TABLE 203. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2032 (USD MILLION)
TABLE 204. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cell Viability Assays market report include:
  • AAT Bioquest, Inc.
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Akadeum Life Sciences
  • Assay Genie
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biotium, Inc.
  • BMG LABTECH GmbH
  • Cell Biolabs, Inc.
  • Creative Bioarray
  • Danaher Corporation
  • Elabscience Biotechnology Inc.
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies, Inc.
  • Hemogenix Inc.
  • Illumina, Inc
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.48 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.85 Billion
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cell Viability Assays - Global Strategic Business Report - Product Image

Cell Viability Assays - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Cell Viability Assays Market Report 2025 - Product Image

Cell Viability Assays Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glycated Albumin Assay Market - Global Forecast 2026-2032 - Product Image

Glycated Albumin Assay Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
GST Assay Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

GST Assay Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Inorganic Phosphorus Detection Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Inorganic Phosphorus Detection Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cell Viability Assay Market

The Cell Viability Assay market is a segment of the Laboratory Testing industry that focuses on the measurement of the number of viable cells in a sample. This type of assay is used to assess the health of cells, as well as to determine the effectiveness of treatments such as drugs or radiation. Cell viability assays are used in a variety of research and clinical applications, including cancer research, stem cell research, and drug development. Cell viability assays are typically performed using a variety of techniques, such as flow cytometry, fluorescent microscopy, and colorimetric assays. These assays are used to measure the number of viable cells in a sample, as well as to assess the health of the cells. Some of the companies in the Cell Viability Assay market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, and Agilent Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.